| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
| 645 | 444 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
| 645 | 444 | | | Operating Expenses | | Research Development | 16,070 | 18,319 | 23,764 | | Selling General and Administrative | 6,537 | 8,150 | 9,644 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (22,607) | (25,824) | (32,964) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,042 | 2,703 | 2,733 | | Earnings Before Interest And Taxes | (21,565) | (23,121) | (30,231) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (21,565) | (23,121) | (30,231) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,565) | (23,121) | (30,231) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (21,565) | (23,121) | (30,231) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,565) | ($23,121) | ($30,231) |
|
1.48% Nasdaq 
Income Statement
